PERT Consortium and BTG Form Strategic Partnership


July 2, 2018—BTG International has entered into a strategic partnership with the PERT Consortium to promote the implementation of PERT (pulmonary embolism response team) programs across the United States and to advance the science of pulmonary embolism (PE) treatment. The company announced the collaboration at the 4th Annual PERT Consortium annual meeting held June 22–23 in Nashville, Tennessee.

In their new partnership, BTG and the PERT Consortium will address PE disease via new options for professional education, expanding clinical research, establishing quality benchmarks for the care of PE, and developing new mobile technologies to convene PERT teams and improve decision-making. The company stated that it hopes to develop new strategies to transform the paradigm of PE treatment.

Kenneth Rosenfield, MD, who is Immediate Past President of the PERT Consortium, commented in the announcement, “PE is a pervasive disease that is underrecognized and undertreated. Our collaboration with BTG will enable the PERT Consortium to increase provider and patient awareness about PE and establish new benchmarks for high-quality care of the patient with this disease.”

In 2012, the first PERT was created by a multidisciplinary team of physicians at Massachusetts General Hospital in Boston, Massachusetts to develop the necessary clinical, educational, and research infrastructure for the advancement of PE care. Since then, the PERT multidisciplinary approach has allowed for the streamlined evaluation of patients, formulation of comprehensive treatment plans, and the rapid mobilization of resources to provide the highest level of care to those in need. The PERT model continues to be adopted by institutions across the United States and internationally, noted the announcement.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.